Acta Neuropathologica

, Volume 72, Issue 1, pp 55–61 | Cite as

Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin

  • B. Schwerer
  • H. Lassmann
  • K. Kitz
  • H. Bernheimer
Original Works


Ganglioside-antisera, the ganglioside GM1-ligands, cholera toxin (CT), and CT subunit B, respectively, were injected into the lumbosacral subarachnoid space of normal rats. The cytotoxic effects of the injected compounds on the peripheral and central nervous system were investigated by light and electron microscopy; the severity of CNS lesions was evaluated by quantitation of macrophages containing debris. In contrast to control sera and GM2-antiserum, antisera against a mixture of the major brain gangliosides GM1, GD1a, GD1b, and GT1b (MaBG) or against GM1 induced demyelination in spinal roots and spinal cord, as well as alterations of astroglia. CT induced the same cytotoxic effects as MaBG- and GM1-antisera, whereas CT subunit B was without effect. The ineffectiveness of GM2-antiserum is obviously due to the very low concentration of the specific binding target, GM2, on cell surfaces; that of CT subunit B to the lack of the cytotoxic operator, subunit A. Our results indicate that a similar pattern of neuropathological lesions may be effected by different cytotoxic mechanisms through attachment of the cytotoxic agent onto the cell surface via a common target molecule, and further substantiate the role of GM1-antibodies in the pathogenesis of demyelination.

Key words

Ganglioside-antibodies Cholera toxin Cytotoxicity Demyelination 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abe T, Norton WT (1974) The characterization of sphingolipids from neurons and astroglia of immature rat brain. J Neurochem 23:1025–1036Google Scholar
  2. Arnon R, Crisp E, Kelley R, Ellison GW, Myers LW, Tourtellotte WW (1980) Anti-ganglioside antibodies in multiple sclerosis. J Neurol Sci 46:179–186Google Scholar
  3. Chou KH, Nolan CE, Jungalwala FB (1982) Composition and metabolism of gangliosides in rat peripheral nervous system during development. J Neurochem 39:1547–1558Google Scholar
  4. Cochran FB, Yu RK, Ledeen RW (1982) Myelin gangliosides in vertebrates. J Neurochem 39:773–779Google Scholar
  5. Cohen O, Sela BA, Schwartz M, Eshhar N, Cohen IR (1981) Multiple sclerosis-like disease induced in rabbits by immunization with brain gangliosides. Isr J Med Sci 17:711–714Google Scholar
  6. DeVries GH, Hadfield MG, Cornbrooks C (1976) The isolation and lipid composition of myelin-free axons from rat CNS. J Neurochem 26:725–731Google Scholar
  7. Endo T, Scott DD, Stewart SS, Kundu SK, Marcus DM (1984) Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. J Immunol 132:1793–1797Google Scholar
  8. Fong JW, Ledeen RW, Kundu SK, Brostoff SW (1976) Gangliosides of peripheral nerve myelin. J Neurochem 26:157–162Google Scholar
  9. Gregson NA, Kennedey M, Leibowitz S (1977) Gangliosides as surface antigens on cells isolated from the rat cerebellar cortex. Nature 266:461–463Google Scholar
  10. Karpiak SE, Graf L, Rapport MM (1976) Antiserum to brain gangliosides produces recurrent epileptiform activity. Science 194:735–737Google Scholar
  11. Karpiak SE, Mahadik SP, Rapport MM (1978) Ganglioside receptors and induction of epileptiform activity: Cholera toxin and choleragenoid (B subunits). Exp Neurol 62:256–259Google Scholar
  12. Kasarskis EJ, Karpiak SE, Rapport MM, Yu RK, Bass NH (1981) Abnormal maturation of cerebral cortex and behavioral deficit in adult rats after neonatal administration of antibodies to ganglioside. Dev Brain Res 1:25–35Google Scholar
  13. Kitz K, Lassmann H, Wisniewski HM (1981) Isolated leptomeninges of the spinal cord: An ideal tool to study inflammatory reaction in EAE. Acta Neuropathol (Berl) [Suppl] 7:179–181Google Scholar
  14. Klein F, Mandel P (1975) Gangliosides of the peripheral nervous system of the rat. Life Sci 16:751–757Google Scholar
  15. Lai CY (1980) The chemistry and biology of cholera toxin. CRC Crit Rev Biochem 9:171–206Google Scholar
  16. Lassmann H, Kitz K, Wisniewski HM (1981) In vivo effect of sera from animals with chronic relapsing experimental allergic encephalomyelitis on central and peripheral myelin. Acta Neuropathol (Berl) 55:297–306Google Scholar
  17. Ledeen RW (1978) Ganglioside structures and distribution: are they localized at the nerve ending? J Supramol Struct 8:1–17Google Scholar
  18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275Google Scholar
  19. Merlis JK (1940) The effect of changes in the calcium content of the cerebrospinal fluid on spinal reflex activity in the dog. Am J Physiol 131:67–72Google Scholar
  20. Nagai Y, Momoi T, Saito M, Mitsuzawa E, Ohtani S (1976) Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides. Neurosci Lett 2:107–111Google Scholar
  21. Nagai Y, Uchida T, Takeda S, Ikuta F (1978) Restoration of activity for induction of experimental allergic peripheral neuritis by a combination of myelin basic protein P2 and gangliosides from peripheral nerve. Neurosci Lett 8:247–254Google Scholar
  22. Naiki M, Marcus DM, Ledeen R (1974) Properties of antisera to ganglioside GM1 and asialo GM1. J Immunol 113:84–93Google Scholar
  23. Pascal TA, Saifer A (1969) Immunochemical studies of isolated human brain ganglioside components. J Neurochem 16:301–307Google Scholar
  24. Rapport MM, Graf L (1969) Immunochemical reactions of lipids. Prog Allergy 13:273–331Google Scholar
  25. Rapport MM, Graf L, Huang YL, Brunner W, Yu RK (1980) Antibodies to total brain gangliosides: titer and specificity of antisera. In: Svennerholm L, Mandel P, Dreyfus H, Urban PF (eds) Structure and function of gangliosides. Plenum, New York, pp 327–334Google Scholar
  26. Roth GA, Röyttä M, Yu RK, Raine CS, Bornstein MB (1985) Antisera to different glycolipids induce myelin alterations in mouse spinal cord tissue cultures. Brain Res 339:9–18Google Scholar
  27. Schwerer B, Lassmann H, Bernheimer H (1982) Antisera against ganglioside GM2: immunochemical and immunohistological studies. Neuropathol Appl Neurobiol 8:217–226Google Scholar
  28. Schwerer B, Kitz K, Lassmann H, Bernheimer H (1984) Serum antibodies against glycosphingolipids in chronic relapsing experimental allergic encephalomyelitis. Demonstration by ELISA and relation to serum in vivo demyelinating activity. J Neuroimmunol 7:107–119Google Scholar
  29. Suzuki K, Poduslo JF, Poduslo SE (1968) Further evidence for a specific ganglioside fraction closely associated with myelin. Biochim Biophys Acta 152:576–586Google Scholar
  30. Svennerholm L (1963) Chromatographic separation of human brain gangliosides. J Neurochem 10:613–623Google Scholar
  31. Tabira T, Endoh M (1985) Humoral immune response to myelin basic protein, cerebroside and ganglioside in chronic relapsing experimental allergic encephalomyelitis of the guinea pig. J Neurol Sci 67:201–212Google Scholar
  32. Wasserman E, Levine L (1961) Quantitative micro-complement fixation and its use in the study of antigenic structure by specific antigen-antibody inhibition. J Immunol 87:290–295Google Scholar
  33. Yonezawa T, Saida T, Hasegawa M (1976) Myelination inhibiting factor in experimental allergic encephalomyelitis and demyelinating diseases. In: Shiraki H, Yonezawa T, Kuroiwa Y (eds) The aetiology and pathogenesis of the demyelinating diseases. Japan Science Press, Kyoto, pp 255–263Google Scholar
  34. Yu RK, Iqbal K (1979) Sialosylgalactosyl ceramide as a specific marker for human myelin and oligodendroglial perikarya: gangliosides of human myelin, oligodendroglia and neurons. J Neurochem 32:293–300Google Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • B. Schwerer
    • 1
  • H. Lassmann
    • 1
  • K. Kitz
    • 1
  • H. Bernheimer
    • 1
  1. 1.Neurological InstituteUniversity of ViennaViennaAustria

Personalised recommendations